Cargando…

The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography

BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yuna, Lee, Seunghyun, Hur, Saebeom, Jeong, Yun Soo, Suh, Dong In, Moon, Jangsup, Kim, Man Jin, Choi, Young Hun, Cheon, Jung-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131433/
https://www.ncbi.nlm.nih.gov/pubmed/37101303
http://dx.doi.org/10.1186/s13023-023-02704-7
_version_ 1785031176734375936
author Lee, Yuna
Lee, Seunghyun
Hur, Saebeom
Jeong, Yun Soo
Suh, Dong In
Moon, Jangsup
Kim, Man Jin
Choi, Young Hun
Cheon, Jung-Eun
author_facet Lee, Yuna
Lee, Seunghyun
Hur, Saebeom
Jeong, Yun Soo
Suh, Dong In
Moon, Jangsup
Kim, Man Jin
Choi, Young Hun
Cheon, Jung-Eun
author_sort Lee, Yuna
collection PubMed
description BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 patients with GSD between January 2001 and December 2020. After December 2018, DCMRL examinations were performed for lymphatic vessel evaluation in patients with GSD and reviewed in four patients. RESULTS: The median age at diagnosis was 9 years (range: 2 months–53 years). The clinical manifestations were dyspnea in seven patients (46.7%), sepsis in 12 (80.0%), orthopedic problems in seven (46.7%), and bloody chylothorax in seven (46.7%). The common sites of osseous involvement were the spine (73.3%) and pelvic bone (60.0%). Among the non-osseous involvements, peri-osseous infiltrative soft-tissue abnormalities adjacent to the area of bone involvement were the most common (86.7%), followed by splenic cysts (26.7%) and interstitial thickening (26.7%). DCMRL demonstrated weak central conducting lymphatic flow in two patients with abnormal giant tortuous thoracic ducts and no flow in one patient. All patients who underwent DCMRL in this study presented with altered anatomical lymphatics and functional flow with collateralization. CONCLUSION: DCMRL imaging and plain radiography are very useful for determining the extent of GSD. DCMRL is a novel imaging tool for the visualization of abnormal lymphatics in patients with GSD, which helps in further treatment. Therefore, in patients with GSD, it might be necessary to obtain not only plain radiographs but also MR and DCMRL images. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02704-7.
format Online
Article
Text
id pubmed-10131433
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101314332023-04-27 The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography Lee, Yuna Lee, Seunghyun Hur, Saebeom Jeong, Yun Soo Suh, Dong In Moon, Jangsup Kim, Man Jin Choi, Young Hun Cheon, Jung-Eun Orphanet J Rare Dis Research BACKGROUND: To describe the radiological features of Gorham–Stout disease (GSD) as evaluated using plain radiography and dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) imaging techniques. METHODS: Clinical and conventional imaging data were retrospectively reviewed for 15 patients with GSD between January 2001 and December 2020. After December 2018, DCMRL examinations were performed for lymphatic vessel evaluation in patients with GSD and reviewed in four patients. RESULTS: The median age at diagnosis was 9 years (range: 2 months–53 years). The clinical manifestations were dyspnea in seven patients (46.7%), sepsis in 12 (80.0%), orthopedic problems in seven (46.7%), and bloody chylothorax in seven (46.7%). The common sites of osseous involvement were the spine (73.3%) and pelvic bone (60.0%). Among the non-osseous involvements, peri-osseous infiltrative soft-tissue abnormalities adjacent to the area of bone involvement were the most common (86.7%), followed by splenic cysts (26.7%) and interstitial thickening (26.7%). DCMRL demonstrated weak central conducting lymphatic flow in two patients with abnormal giant tortuous thoracic ducts and no flow in one patient. All patients who underwent DCMRL in this study presented with altered anatomical lymphatics and functional flow with collateralization. CONCLUSION: DCMRL imaging and plain radiography are very useful for determining the extent of GSD. DCMRL is a novel imaging tool for the visualization of abnormal lymphatics in patients with GSD, which helps in further treatment. Therefore, in patients with GSD, it might be necessary to obtain not only plain radiographs but also MR and DCMRL images. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02704-7. BioMed Central 2023-04-26 /pmc/articles/PMC10131433/ /pubmed/37101303 http://dx.doi.org/10.1186/s13023-023-02704-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Yuna
Lee, Seunghyun
Hur, Saebeom
Jeong, Yun Soo
Suh, Dong In
Moon, Jangsup
Kim, Man Jin
Choi, Young Hun
Cheon, Jung-Eun
The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title_full The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title_fullStr The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title_full_unstemmed The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title_short The spectrum of imaging manifestations of Gorham–Stout disease: a novel dynamic contrast-enhanced MR lymphangiography
title_sort spectrum of imaging manifestations of gorham–stout disease: a novel dynamic contrast-enhanced mr lymphangiography
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131433/
https://www.ncbi.nlm.nih.gov/pubmed/37101303
http://dx.doi.org/10.1186/s13023-023-02704-7
work_keys_str_mv AT leeyuna thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT leeseunghyun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT hursaebeom thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT jeongyunsoo thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT suhdongin thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT moonjangsup thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT kimmanjin thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT choiyounghun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT cheonjungeun thespectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT leeyuna spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT leeseunghyun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT hursaebeom spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT jeongyunsoo spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT suhdongin spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT moonjangsup spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT kimmanjin spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT choiyounghun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography
AT cheonjungeun spectrumofimagingmanifestationsofgorhamstoutdiseaseanoveldynamiccontrastenhancedmrlymphangiography